nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.146	0.328	CbGbCtD
Citalopram—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.118	0.264	CbGbCtD
Citalopram—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.111	0.249	CbGbCtD
Citalopram—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0705	0.158	CbGbCtD
Citalopram—Joint dislocation—Cyclosporine—focal segmental glomerulosclerosis	0.0277	0.0499	CcSEcCtD
Citalopram—Unspecified disorder of autonomic nervous system—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0245	CcSEcCtD
Citalopram—Autonomic neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0207	CcSEcCtD
Citalopram—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0186	CcSEcCtD
Citalopram—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.018	CcSEcCtD
Citalopram—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.018	CcSEcCtD
Citalopram—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00865	0.0156	CcSEcCtD
Citalopram—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00865	0.0156	CcSEcCtD
Citalopram—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.00801	0.0144	CcSEcCtD
Citalopram—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.00731	0.0132	CcSEcCtD
Citalopram—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00716	0.0129	CcSEcCtD
Citalopram—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.0124	CcSEcCtD
Citalopram—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.0124	CcSEcCtD
Citalopram—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.0102	CcSEcCtD
Citalopram—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.00988	CcSEcCtD
Citalopram—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0054	0.00973	CcSEcCtD
Citalopram—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0054	0.00973	CcSEcCtD
Citalopram—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00871	CcSEcCtD
Citalopram—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00871	CcSEcCtD
Citalopram—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.00849	CcSEcCtD
Citalopram—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00829	CcSEcCtD
Citalopram—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00829	CcSEcCtD
Citalopram—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00449	0.00809	CcSEcCtD
Citalopram—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.008	CcSEcCtD
Citalopram—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.008	CcSEcCtD
Citalopram—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00773	CcSEcCtD
Citalopram—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00773	CcSEcCtD
Citalopram—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00773	CcSEcCtD
Citalopram—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00748	CcSEcCtD
Citalopram—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00748	CcSEcCtD
Citalopram—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00725	CcSEcCtD
Citalopram—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00703	CcSEcCtD
Citalopram—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.0069	CcSEcCtD
Citalopram—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.00677	CcSEcCtD
Citalopram—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.00671	CcSEcCtD
Citalopram—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00664	CcSEcCtD
Citalopram—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00658	CcSEcCtD
Citalopram—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.00652	CcSEcCtD
Citalopram—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00359	0.00647	CcSEcCtD
Citalopram—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00624	CcSEcCtD
Citalopram—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00609	CcSEcCtD
Citalopram—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.00604	CcSEcCtD
Citalopram—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00599	CcSEcCtD
Citalopram—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00599	CcSEcCtD
Citalopram—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00599	CcSEcCtD
Citalopram—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00594	CcSEcCtD
Citalopram—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00576	CcSEcCtD
Citalopram—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00559	CcSEcCtD
Citalopram—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00543	CcSEcCtD
Citalopram—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00539	CcSEcCtD
Citalopram—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00535	CcSEcCtD
Citalopram—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00535	CcSEcCtD
Citalopram—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00531	CcSEcCtD
Citalopram—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00524	CcSEcCtD
Citalopram—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00521	CcSEcCtD
Citalopram—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00521	CcSEcCtD
Citalopram—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00517	CcSEcCtD
Citalopram—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00517	CcSEcCtD
Citalopram—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00517	CcSEcCtD
Citalopram—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00517	CcSEcCtD
Citalopram—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.0051	CcSEcCtD
Citalopram—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.0051	CcSEcCtD
Citalopram—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00507	CcSEcCtD
Citalopram—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00504	CcSEcCtD
Citalopram—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00494	CcSEcCtD
Citalopram—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00479	CcSEcCtD
Citalopram—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.0047	CcSEcCtD
Citalopram—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00462	CcSEcCtD
Citalopram—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00457	CcSEcCtD
Citalopram—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00454	CcSEcCtD
Citalopram—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00454	CcSEcCtD
Citalopram—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00449	CcSEcCtD
Citalopram—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.00446	CcSEcCtD
Citalopram—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00441	CcSEcCtD
Citalopram—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00432	CcSEcCtD
Citalopram—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0043	CcSEcCtD
Citalopram—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0043	CcSEcCtD
Citalopram—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00425	CcSEcCtD
Citalopram—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00425	CcSEcCtD
Citalopram—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00421	CcSEcCtD
Citalopram—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.0041	CcSEcCtD
Citalopram—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00408	CcSEcCtD
Citalopram—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00408	CcSEcCtD
Citalopram—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.004	CcSEcCtD
Citalopram—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00392	CcSEcCtD
Citalopram—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00389	CcSEcCtD
Citalopram—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00385	CcSEcCtD
Citalopram—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00382	CcSEcCtD
Citalopram—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00382	CcSEcCtD
Citalopram—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00382	CcSEcCtD
Citalopram—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0038	CcSEcCtD
Citalopram—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0038	CcSEcCtD
Citalopram—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00378	CcSEcCtD
Citalopram—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00371	CcSEcCtD
Citalopram—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00368	CcSEcCtD
Citalopram—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00365	CcSEcCtD
Citalopram—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00363	CcSEcCtD
Citalopram—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00362	CcSEcCtD
Citalopram—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.0036	CcSEcCtD
Citalopram—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00357	CcSEcCtD
Citalopram—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00354	CcSEcCtD
Citalopram—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00351	CcSEcCtD
Citalopram—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0035	CcSEcCtD
Citalopram—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0035	CcSEcCtD
Citalopram—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00348	CcSEcCtD
Citalopram—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00341	CcSEcCtD
Citalopram—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00339	CcSEcCtD
Citalopram—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00336	CcSEcCtD
Citalopram—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00336	CcSEcCtD
Citalopram—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00323	CcSEcCtD
Citalopram—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00313	CcSEcCtD
Citalopram—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00312	CcSEcCtD
Citalopram—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00308	CcSEcCtD
Citalopram—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00307	CcSEcCtD
Citalopram—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00302	CcSEcCtD
Citalopram—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00301	CcSEcCtD
Citalopram—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00297	CcSEcCtD
Citalopram—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00295	CcSEcCtD
Citalopram—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0029	CcSEcCtD
Citalopram—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00289	CcSEcCtD
Citalopram—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00287	CcSEcCtD
Citalopram—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00284	CcSEcCtD
Citalopram—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00283	CcSEcCtD
Citalopram—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00276	CcSEcCtD
Citalopram—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00274	CcSEcCtD
Citalopram—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00273	CcSEcCtD
Citalopram—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00268	CcSEcCtD
Citalopram—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00267	CcSEcCtD
Citalopram—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00266	CcSEcCtD
Citalopram—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00265	CcSEcCtD
Citalopram—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00263	CcSEcCtD
Citalopram—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00263	CcSEcCtD
Citalopram—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00262	CcSEcCtD
Citalopram—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00259	CcSEcCtD
Citalopram—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00258	CcSEcCtD
Citalopram—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00258	CcSEcCtD
Citalopram—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00256	CcSEcCtD
Citalopram—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00256	CcSEcCtD
Citalopram—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00256	CcSEcCtD
Citalopram—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00256	CcSEcCtD
Citalopram—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00251	CcSEcCtD
Citalopram—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00249	CcSEcCtD
Citalopram—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00248	CcSEcCtD
Citalopram—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00247	CcSEcCtD
Citalopram—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00237	CcSEcCtD
Citalopram—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00237	CcSEcCtD
Citalopram—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00236	CcSEcCtD
Citalopram—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00236	CcSEcCtD
Citalopram—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00235	CcSEcCtD
Citalopram—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00234	CcSEcCtD
Citalopram—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00233	CcSEcCtD
Citalopram—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00232	CcSEcCtD
Citalopram—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00231	CcSEcCtD
Citalopram—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00228	CcSEcCtD
Citalopram—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0022	CcSEcCtD
Citalopram—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00219	CcSEcCtD
Citalopram—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00214	CcSEcCtD
Citalopram—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00213	CcSEcCtD
Citalopram—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00212	CcSEcCtD
Citalopram—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00211	CcSEcCtD
Citalopram—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00209	CcSEcCtD
Citalopram—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00207	CcSEcCtD
Citalopram—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00206	CcSEcCtD
Citalopram—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00203	CcSEcCtD
Citalopram—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00202	CcSEcCtD
Citalopram—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00201	CcSEcCtD
Citalopram—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.002	CcSEcCtD
Citalopram—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00198	CcSEcCtD
Citalopram—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00194	CcSEcCtD
Citalopram—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00193	CcSEcCtD
Citalopram—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00191	CcSEcCtD
Citalopram—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0019	CcSEcCtD
Citalopram—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00189	CcSEcCtD
Citalopram—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00188	CcSEcCtD
Citalopram—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00185	CcSEcCtD
Citalopram—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00185	CcSEcCtD
Citalopram—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00184	CcSEcCtD
Citalopram—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000996	0.00179	CcSEcCtD
Citalopram—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.00178	CcSEcCtD
Citalopram—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000985	0.00177	CcSEcCtD
Citalopram—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000972	0.00175	CcSEcCtD
Citalopram—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000972	0.00175	CcSEcCtD
Citalopram—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000972	0.00175	CcSEcCtD
Citalopram—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000968	0.00174	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.00174	CcSEcCtD
Citalopram—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.00173	CcSEcCtD
Citalopram—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00095	0.00171	CcSEcCtD
Citalopram—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000939	0.00169	CcSEcCtD
Citalopram—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.00168	CcSEcCtD
Citalopram—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.00168	CcSEcCtD
Citalopram—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000925	0.00167	CcSEcCtD
Citalopram—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000913	0.00165	CcSEcCtD
Citalopram—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000912	0.00164	CcSEcCtD
Citalopram—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000905	0.00163	CcSEcCtD
Citalopram—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0009	0.00162	CcSEcCtD
Citalopram—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000888	0.0016	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000849	0.00153	CcSEcCtD
Citalopram—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000842	0.00152	CcSEcCtD
Citalopram—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000836	0.00151	CcSEcCtD
Citalopram—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00083	0.0015	CcSEcCtD
Citalopram—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000828	0.00149	CcSEcCtD
Citalopram—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00082	0.00148	CcSEcCtD
Citalopram—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.00146	CcSEcCtD
Citalopram—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000804	0.00145	CcSEcCtD
Citalopram—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00145	CcSEcCtD
Citalopram—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.00143	CcSEcCtD
Citalopram—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.00143	CcSEcCtD
Citalopram—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000768	0.00138	CcSEcCtD
Citalopram—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.00137	CcSEcCtD
Citalopram—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00074	0.00133	CcSEcCtD
Citalopram—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000736	0.00133	CcSEcCtD
Citalopram—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000736	0.00133	CcSEcCtD
Citalopram—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.00124	CcSEcCtD
Citalopram—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.0012	CcSEcCtD
Citalopram—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00119	CcSEcCtD
Citalopram—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.00115	CcSEcCtD
Citalopram—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000616	0.00111	CcSEcCtD
Citalopram—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000592	0.00107	CcSEcCtD
Citalopram—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.00106	CcSEcCtD
Citalopram—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.00106	CcSEcCtD
Citalopram—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.00105	CcSEcCtD
Citalopram—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.000996	CcSEcCtD
